Last reviewed · How we verify

NCT06939062

B-TURP vs BipolEP in Management of BPH Patients With Medium-sized Prostates

Completed NA Last updated 24 July 2025
What this trial tests

NA trial testing Bipolar enucleation of the prostate (BipolEP) in Benign Prostatic Hyperplasia in 63 participants. Completed in 1 July 2025.

Timeline
1 July 2022
Primary endpoint
1 June 2025
1 July 2025

Quick facts

Lead sponsorAssiut University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment63
Start date1 July 2022
Primary completion1 June 2025
Estimated completion1 July 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Assiut University

Who can join

Adults 45 to 80, male only, with Benign Prostatic Hyperplasia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a comparative study of the efficacy and safety of endoscopic bipolar transurethral resection and enucleation of the prostate in management of benign prostatic hyperplasia patients with medium-sized prostates

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Bipolar enucleation of the prostate (BipolEP)

Trials testing the same drug.

Other recruiting trials for Benign Prostatic Hyperplasia

Currently open trials in the same condition.

Other Assiut University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06939062.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing